Concepedia

Jermaine D. Jones

JD

Statistics

Publications

48

Citations

1.7K

H-Index

24

Active since

2005

Affiliations

Columbia University(Current)

New York Psychoanalytic Society and Institute

New York State Psychiatric Institute

Columbia University Irving Medical Center

City College of New York

Jermaine D. Jones is an author at Columbia University specializing in substance use disorders, pharmacology, and pharmacotherapy.

ORCID

Publications per year

2005–2023

48

Publications

48

The effects of ibudilast, a glial activation inhibitor, on opioid withdrawal symptoms in opioid-dependent volunteers

Ziva D. Cooper, Kirk W. Johnson, Martina Pavlicová et al. · Addiction Biology · 2015 · 149 citations · Full text

, , +14

Effects of Ibudilast on the Subjective, Reinforcing, and Analgesic Effects of Oxycodone in Recently Detoxified Adults with Opioid Dependence

Verena E. Metz, Jermaine D. Jones, Jeanne M. Manubay et al. · Neuropsychopharmacology · 2017 · 128 citations · Full text

, , +16

Effect of Buprenorphine Weekly Depot (CAM2038) and Hydromorphone Blockade in Individuals With Opioid Use Disorder

Sharon Walsh, Sandra D. Comer, Michelle R. Lofwall et al. · JAMA Psychiatry · 2017 · 78 citations · Full text

, , +8

No evidence of compensatory drug use risk behavior among heroin users after receiving take-home naloxone

Jermaine D. Jones, Aimee Campbell, Verena E. Metz et al. · Addictive Behaviors · 2017 · 77 citations · Full text

, , +12

The PPARγ Agonist Pioglitazone Fails to Alter the Abuse Potential of Heroin, But Does Reduce Heroin Craving and Anxiety

Jermaine D. Jones, Adam Bisaga, Verena E. Metz et al. · Journal of Psychoactive Drugs · 2018 · 74 citations · Full text

, , +14

1–5 of 48